Skip to main content
FLUBLOK TRIVALENT NORTHERN HEMISPHERE 45 ug/.5mL, 45 ug/.5mL, 45 ug/.5mL injection by Sanofi Vaccines US Inc.
FLUBLOK TRIVALENT NORTHERN HEMISPHERE, 45 ug/.5mL, 45 ug/.5mL, 45 ug/.5mL, injection Available on prescription only. Listed by Sanofi Vaccines US Inc..
Prescription only

FLUBLOK TRIVALENT NORTHERN HEMISPHERE

INFLUENZA A VIRUS A/Missouri/11/2025 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/Darwin/1415/2025 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/Pennsylvania/14/2025 RECOMBINANT HEMAGGLUTININ ANTIGEN

Listed by Sanofi Vaccines US Inc.

Strength
45 ug/.5mL, 45 ug/.5mL, 45 ug/.5mL
Form
Injection
Route
Intramuscular

What it contains

  • Influenza A Virus A/missouri/11/2025 (h1n1) Recombinant Hemagglutinin Antigen 45 ug/.5mL
  • Influenza A Virus A/darwin/1415/2025 (h3n2) Recombinant Hemagglutinin Antigen 45 ug/.5mL
  • Influenza B Virus B/pennsylvania/14/2025 Recombinant Hemagglutinin Antigen 45 ug/.5mL

This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.

FDA record

Dosage form Injection
Route Intramuscular
Approval route BLA — biologic licence
NDC code 49281-726
FDA application BLA125285
Package sizes listed 1
Marketed since July 2026

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.